34 results
S-4
EX-99.5
KA
Kineta Inc
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
not thereby admit that we are experts with respect to any part of such Registration Statement within the meaning of the term “expert” as used
8-K
EX-2.2
KA
Kineta Inc
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
Date, including the documented fees and out-of-pocket expenses of the CVR Holders’ Representative, the Holders Valuation Expert Fee, any other … valuation expert selected by PTI and the CVR Holders’ Representative, whose decision shall be binding on the parties hereto and every Holder. The fees
425
EX-2.2
KA
Kineta Inc
24 Aug 20
Business combination disclosure
5:28pm
Date, including the documented fees and out-of-pocket expenses of the CVR Holders’ Representative, the Holders Valuation Expert Fee, any other … valuation expert selected by PTI and the CVR Holders’ Representative, whose decision shall be binding on the parties hereto and every Holder. The fees
8-K
EX-10.1
KA
Kineta Inc
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
the Closing Date, including the documented fees and out-of-pocket expenses of the CVR Holders’ Representative, the Holders Valuation Expert Fee, any … thereafter shall be resolved by an independent third party valuation expert selected by PTI and the CVR Holders’ Representative, whose decision shall
8-K
EX-10.7
KA
Kineta Inc
30 Dec 20
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
4:44pm
or used by a party’s witness or expert. The arbitrator’s decision and award shall be made and delivered within six months of the selection … or considered or used by a party’s witness or expert. The arbitrator’s decision and award shall be made and delivered within six months
S-4/A
EX-10.25
1noqw85 gjsqklo
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
S-4/A
EX-10.22
jm1b5om0g9c b2koxt
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
425
knjvcokcsuvq 80b6
9 Dec 20
Business combination disclosure
5:25pm
8-K
4ch2r5 va
9 Dec 20
Other Events
5:27pm
8-K
EX-3.3
x2vn 3u5km
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
S-4
EX-10.20
vrkq90imud93bh9wbu
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
425
EX-3.1
x6n3 3o8qsr3
24 Aug 20
Business combination disclosure
5:28pm
8-K
EX-3.1
1hexf8xwuz81 dq08
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm